0.05 | 1.41%
| Price and Volume | |
|---|---|
| Recent Price | 3.55 |
| 52 Week High | 4.79 |
| 52 Week Low | 2.54 |
| Avg. Daily Vol. (Mil) | 0.17 |
| Beta (3 year) | 1.42 |
| Share Related Items | |
| Mkt Cap (Mil) | 198.21 |
| Shares Out (Mil) | 55.83 |
| Float (Mil) | 54.83 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.10 |
| Current Ratio | 4.90 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | 20.90 |
| Price/Sales | 1.15 |
| Price/Book | 1.13 |
| Price/Cash Flow | 15.70 |
| Per Share Data | |
| Earnings | 0.17 |
| Sales | 3.09 |
| Book Value | 3.15 |
| Cash Flow | 0.23 |
| Business Summary | |
|---|---|
| RTI Biologics, Inc. is engaged in the use of natural tissues and innovative technologies to produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. | |
| General Information | |
| 11621 Research Circle
Alachua, FL 32615 |
|
| www.rtix.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 706 | |
| CEO: Brian K. Hutchison | |
| Short Interest | |
| Current Month (Mil) | 2.23 |
| Previous Month (Mil) | 2.14 |
| Short Interest Ratio (Days) | 14.30 |
| Management Effectiveness | |
| Return on Equity | 5.20 |
| Return on Assets | 3.90 |
| Return on Investments | 5.20 |
| Profitability | |
| Gross Margin | 47.80 |
| EBIT Margin | 7.40 |
| Profit Margin | 5.30 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,427.32 | 1,316.31 | 2,834.88 | 16.34 |
Oil *
103.50
|
|
DOWN
153.37 |
DOWN
16.11 |
DOWN
36.11 |
DOWN
0.97 |
10 Yr
1.63%
SPDR Gold
150.63
|
|
-1.22%
|
-1.21%
|
-1.26%
|
-5.60%
|
Data delayed 20 minutes |
Connect with TheStreet